Back to Screener

Healthcare

Catalent, Inc.(CTLT)

Live Price

Offline

$63.48

+0.00% today

1Y Change

—

Window

No data

Market Cap
$11.52B
Revenue Growth
+2.5%
EPS Growth
-350.0%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Catalent, Inc. (CTLT) is a Healthcare stock with a market cap of $11.52B. The stock last traded around $63.48. Baseline metrics include revenue growth of +2.5%, EPS growth of -350.0%, a dividend yield of 0.0%. What stands out right now is revenue +2.5%, EPS -350.0%, free cash flow +81.7% with operating margin -17.1% and ROIC -8.5%. Valuation is more restrained than many high-expectation growth names at price/sales 2.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CTLT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

+2.5% vs +7.6% peer median

Operating Margin

Below sector median

-17.1% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2024 was reported on Nov 5, 2024 with an EPS surprise of -340.7% and a revenue surprise of -3.3%.

The operating picture looks softer than before

Revenue is at +2.5% and EPS is at -350.0%, with operating margin around -17.1%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

CTLT

—

Normalized return

SPY

—

S&P 500

Excess Return

—

Relative to SPY

CTLT Max Drawdown

—

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CTLT and SPY.

Calendar-year return history is still loading or unavailable.
CA

Company Overview

Catalent, Inc.

Last Updated
May 8, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
—
EV/EBITDA
—
Price/Sales
2.6
Price/Book
3.2

Growth

Revenue
+2.5%
EPS
-350.0%
Free Cash Flow
+81.7%

Profitability

Gross Margin
21.8%
Operating Margin
-17.1%
Net Margin
-23.8%
ROE
-25.3%
ROIC
-8.5%

Balance Sheet

Debt/Equity
1.36
Current Ratio
2.52

Earnings Reports

📅 Last reportedNov 5, 2024
PeriodB/MEPSEPS ΔRevenueRev Δ
—
Nov 5, 24
✗
-0.13
Est -0.03
-340.7%
1023000.0B
Est 1058403.3B
-3.3%
—
Aug 29, 24
✓
0.65
Est 0.47
+39.3%
1301000.0B
Est 1223999.3B
+6.3%
—
May 8, 24
✗
-0.06
Est 0.22
-127.9%
1074000.0B
Est 1122449.6B
-4.3%
—
Feb 9, 24
✗
-0.24
Est -0.02
-1055.5%
1024000.0B
Est 1118350.0B
-8.4%
—
Nov 15, 23
✓
-0.10
Est -0.13
+23.1%
982000.0B
Est 940190.0B
+4.5%
—
Aug 29, 23
✗
0.09
Est 0.10
-10.0%
1068000.0B
Est 1053160.0B
+1.4%
—
Jun 12, 23
✓
-0.09
Est -0.13
+30.8%
1037000.0B
Est 952660.0B
+8.8%
—
Feb 7, 23
✗
0.67
Est 0.72
-6.9%
1149000.0B
Est 1124179.5B
+2.2%
—
Nov 1, 22
✗
0.34
Est 0.55
-38.2%
4276000.0B
Est 1077643.9B
+296.8%
—
Aug 29, 22
✓
1.19
Est 1.15
+3.5%
1313000.0B
Est 1326940.2B
-1.1%
—
May 3, 22
✓
1.04
Est 0.94
+10.6%
1273000.0B
Est 1218584.9B
+4.5%
—
Feb 1, 22
✓
0.90
Est 0.84
+7.1%
1217000.0B
Est 1149843.5B
+5.8%
—
Nov 2, 21
✓
0.71
Est 0.66
+7.6%
1025000.0B
Est 1032390.0B
-0.7%
—
Aug 30, 21
✓
1.16
Est 1.03
+12.6%
1188000.0B
Est 1105849.5B
+7.4%
—
May 4, 21
✓
0.82
Est 0.76
+7.9%
1053300.0B
Est 990110.0B
+6.4%
—
Feb 2, 21
✓
0.63
Est 0.56
+12.5%
910800.0B
Est 894580.0B
+1.8%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks